PAID 1.0 in practice: a brief clarification regarding its possibilities and limitations.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Works matching IS 11707690 AND DT 2011 AND VI 29 AND IP 6
Results: 14
1
2
Health technology funding decision-making processes around the world: the same, yet different.
- Published in:
- 2011
- By:
- Publication type:
- journal article
3
Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.
- Published in:
- 2011
- By:
- Publication type:
- journal article
4
The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.
- Published in:
- 2011
- By:
- Publication type:
- journal article
5
Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.
- Published in:
- 2011
- By:
- Publication type:
- journal article
6
A value set for the EQ-5D based on experienced health states: development and testing for the German population.
- Published in:
- 2011
- By:
- Publication type:
- journal article
7
PAID 1.0 in Practice A Brief Clarification Regarding its Possibilities and Limitations.
- Published in:
- 2011
- By:
- Publication type:
- Letter
8
Intravenous Esomeprazole A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 535, doi. 10.2165/11207430-000000000-00000
- By:
- Publication type:
- Article
9
AValue Set for the EQ-5D Based on Experienced Health States.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 521, doi. 10.2165/11538380-000000000-00000
- By:
- Publication type:
- Article
10
The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 511, doi. 10.2165/11584330-000000000-00000
- By:
- Publication type:
- Article
11
A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 497, doi. 10.2165/11589230-000000000-00000
- By:
- Publication type:
- Article
12
Health Technology Funding Decision- Making Processes Around the World.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 475, doi. 10.2165/11586420-000000000-00000
- By:
- Publication type:
- Article
13
Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 461, doi. 10.2165/11589250-000000000-00000
- By:
- Publication type:
- Article
14
The Appropriate Elicitation of Expert Opinion in Economic Models.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 6, p. 455, doi. 10.2165/11589220-000000000-00000
- By:
- Publication type:
- Article